U.S. Gene Therapy Market 2030: The Power of Viral Vectors
The U.S. gene therapy market was valued at USD 3.11 billion in 2023 and is projected to reach USD 10.40 billion by 2030, growing at a compound annual growth rate (CAGR) of 19.21% from 2024 to 2030. Gene therapy encompasses DNA-based treatments that deliver a functional copy of a faulty gene or correct a mutated gene using viral vectors, plasmids, or gene editing tools. A robust...
0 Comments 0 Shares 61 Views 0 Reviews